These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7939528)

  • 1. [Molecular aspects in the pathogenesis of nodules and adenomas of the thyroid gland].
    Derwahl M
    Schweiz Med Wochenschr; 1994 Sep; 124(37):1613-8. PubMed ID: 7939528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.
    Derwahl M
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():32-5. PubMed ID: 8980997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
    Derwahl M; Manole D; Sobke A; Broecker M
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
    Derwahl M
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in thyroid nodular disease.
    Krohn K; Paschke R
    Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts.
    Derwahl M; Studer H
    Exp Clin Endocrinol Diabetes; 2001; 109(5):250-60. PubMed ID: 11507648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Goiter: from epiphenomenon of iodine deficiency to benign tumor. A 30-year long guided story].
    Studer H
    Schweiz Med Wochenschr; 1995 Jul; 125(29):1379-87. PubMed ID: 7676226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway.
    Georgopoulos NA; Sykiotis GP; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Papavassiliou AG; Vagenakis AG
    Eur J Endocrinol; 2003 Oct; 149(4):287-92. PubMed ID: 14514342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
    Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations.
    Krohn K; Wohlgemuth S; Gerber H; Paschke R
    J Pathol; 2000 Sep; 192(1):37-42. PubMed ID: 10951398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.
    Tonacchera M; Vitti P; De Servi M; Agretti P; De Marco G; Chiovato L; Pinchera A
    J Endocrinol Invest; 2003; 26(2 Suppl):2-6. PubMed ID: 12762632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TSH receptor double mutation in functional autonomic thyroid nodule].
    Semlitsch G; Höfler G; Langsteger W; Lax S; Zatloukal K; Berger A; Eber O
    Acta Med Austriaca; 1995; 22(4):75-7. PubMed ID: 8835426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas--a note of caution.
    Derwahl M
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2783-5. PubMed ID: 8768829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
    Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S
    J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland.
    Studer H; Derwahl M
    Endocr Rev; 1995 Aug; 16(4):411-26. PubMed ID: 8521787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced functional activity in thyroid adenomas in vitro.
    Poertl S; Kirner J; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():39-40. PubMed ID: 8980999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular aetiology of nodular goitre -- consequences for therapy?].
    Brauer VF; Paschke R
    Zentralbl Chir; 2004 Oct; 129(5):356-62. PubMed ID: 15486785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.